138 related articles for article (PubMed ID: 27721176)
1. Colon cancer targeting using conjugates biomaterial 5-flurouracil.
Jaferian S; Negahdari B; Eatemadi A
Biomed Pharmacother; 2016 Dec; 84():780-788. PubMed ID: 27721176
[TBL] [Abstract][Full Text] [Related]
2. Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira.
Karan S; Choudhury H; Chakra BK; Chatterjee TK
Asian Pac J Cancer Prev; 2019 Jul; 20(7):2181-2194. PubMed ID: 31350983
[TBL] [Abstract][Full Text] [Related]
3. Integrinβ6-targeted immunoliposomes mediate tumor-specific drug delivery and enhance therapeutic efficacy in colon carcinoma.
Liang B; Shahbaz M; Wang Y; Gao H; Fang R; Niu Z; Liu S; Wang B; Sun Q; Niu W; Liu E; Wang J; Niu J
Clin Cancer Res; 2015 Mar; 21(5):1183-95. PubMed ID: 25549721
[TBL] [Abstract][Full Text] [Related]
4. pH dependent poly[2-(methacryloyloxyethyl)trimetylammonium chloride-co-methacrylic acid]hydrogels for enhanced targeted delivery of 5-fluorouracil in colon cancer cells.
Mishra RK; Ramasamy K; Ahmad NA; Eshak Z; Majeed AB
J Mater Sci Mater Med; 2014 Apr; 25(4):999-1012. PubMed ID: 24398912
[TBL] [Abstract][Full Text] [Related]
5. Strategies of targeting oral drug delivery systems to the colon and their potential use for the treatment of colorectal cancer.
Krishnaiah YS; Khan MA
Pharm Dev Technol; 2012; 17(5):521-40. PubMed ID: 22681390
[TBL] [Abstract][Full Text] [Related]
6. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil.
El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL
Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867
[TBL] [Abstract][Full Text] [Related]
7. Oral 5-fluorouracil colon-specific delivery through in vivo pellet coating for colon cancer and aberrant crypt foci treatment.
Bose A; Elyagoby A; Wong TW
Int J Pharm; 2014 Jul; 468(1-2):178-86. PubMed ID: 24709212
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of 5-fluorouracil to HT-29 cells using high efficient folic acid-conjugated nanoparticles.
Wang Y; Li P; Chen L; Gao W; Zeng F; Kong LX
Drug Deliv; 2015 Feb; 22(2):191-8. PubMed ID: 24437926
[TBL] [Abstract][Full Text] [Related]
9. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model.
Shakeri-Zadeh A; Shiran MB; Khoee S; Sharifi AM; Ghaznavi H; Khoei S
J Biomater Appl; 2014 Oct; 29(4):548-56. PubMed ID: 24913615
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-cancer effect of 5-fluorouracil loaded into thermo-responsive conjugated linoleic acid-incorporated poloxamer hydrogel on metastatic colon cancer models.
Bae WK; Lee JH; Lee SJ; Park MS; Hwang JE; Shim HJ; Cho SH; Guo DD; Cho CS; Park IK; Chung IJ
J Nanosci Nanotechnol; 2011 Feb; 11(2):1425-8. PubMed ID: 21456204
[TBL] [Abstract][Full Text] [Related]
11. A comparison of 5-fluorouracil and natural chemotherapeutic agents, EGCG and thymoquinone, delivered by sustained drug delivery on colon cancer cells.
Norwood AA; Tucci M; Benghuzzi H
Biomed Sci Instrum; 2007; 43():272-7. PubMed ID: 17487093
[TBL] [Abstract][Full Text] [Related]
12. Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer.
Ortiz R; Cabeza L; Arias JL; Melguizo C; Álvarez PJ; Vélez C; Clares B; Áranega A; Prados J
AAPS J; 2015 Jul; 17(4):918-29. PubMed ID: 25894746
[TBL] [Abstract][Full Text] [Related]
13. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
14. New targeted-colon delivery system: in vitro and in vivo evaluation using X-ray imaging.
Yassin AE; Alsarra IA; Alanazi FK; Al-Mohizea AM; Al-Robayan AA; Al-Obeed OA
J Drug Target; 2010 Jan; 18(1):59-66. PubMed ID: 19653868
[TBL] [Abstract][Full Text] [Related]
15. Colon Cancer and Specific Ways to Deliver Drugs to the Large Intestine.
Derakhshankhah H; Izadi Z; Alaei L; Lotfabadi A; Saboury AA; Dinarvand R; Divsalar A; Seyedarabi A; Barzegari E; Evini M
Anticancer Agents Med Chem; 2017; 17(10):1317-1327. PubMed ID: 28270073
[TBL] [Abstract][Full Text] [Related]
16. Intraperitoneal chemotherapy in the management of colon cancer.
Markman M
Semin Oncol; 1999 Oct; 26(5):536-9. PubMed ID: 10528901
[TBL] [Abstract][Full Text] [Related]
17. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives.
Banerjee A; Pathak S; Subramanium VD; G D; Murugesan R; Verma RS
Drug Discov Today; 2017 Aug; 22(8):1224-1232. PubMed ID: 28545838
[TBL] [Abstract][Full Text] [Related]
18. Biocompatible drug delivery system for photo-triggered controlled release of 5-Fluorouracil.
Jin Q; Mitschang F; Agarwal S
Biomacromolecules; 2011 Oct; 12(10):3684-91. PubMed ID: 21863834
[TBL] [Abstract][Full Text] [Related]
19. Insight to drug delivery aspects for colorectal cancer.
Gulbake A; Jain A; Jain A; Jain A; Jain SK
World J Gastroenterol; 2016 Jan; 22(2):582-99. PubMed ID: 26811609
[TBL] [Abstract][Full Text] [Related]
20. BIOCOMPATIBLE TARGETING HYDROGELS FOR BREAST CANCER TREATMENT.
Cassano R; Mellace S; Pellegrino M; Ricchio E; Mauro L; Andò S; Picci N; Trombino S
Mini Rev Med Chem; 2016; 16(8):651-7. PubMed ID: 26156550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
